|
|
|
* - may be subscription-only |
|
|
- Beyond Air: Agreements Expanding Global Distribution
of LungFit PH More
- Gan & Lee Pharmaceuticals: First Participant
Dosed in the US Phase 2 Clinical Study of Bofanglutide
(GZR18) Injection for Overweight or Obesity More
- Glenmark Therapeutics: Launches Polyethylene Glycol
3350, Powder for Solution, 17 Grams/capful (OTC) More
- Hoth Therapeutics: Plans to Submit Expanded Access
Application for HT-001 to Support Cancer Patients in
Need More
- Matinas BioPharma: Appoints Seasoned Biotech Leaders
to Board of Directors More
- NS Pharma: FDA Accepts Biologics License Application
for Duchenne Muscular Dystrophy Cardiomyopathy
Treatment More
- OKYO Pharma: Files for Fast Track Designation With
FDA for Urcosimod to Treat Neuropathic Corneal Pain
More
- OS Therapies: Schedules United Kingdom’s Medicines
and Healthcare Products Regulatory Agency's (MHRA)
Scientific Advice Meeting in the Third Quarter of 2025
for Review of its OST-HER2 Immunotherapy Candidate for
Osteosarcoma More
- Pfizer and Arvinas: Positive Topline Results
From Phase 3 VERITAC-2 Clinical Trial More
More*
More*
More*
- Schrödinger: Expands Board of Directors With
Appointment of Bridget van Kralingen More
- Tevogen Bio: Unique T Cell Vaccine Under
Development and Files Patent With the USPTO More
|
|
|
- Bristol Myers Buys Out Cell Therapy Partner
2seventy Bio More*
More*
- Legend Biotech: Fourth Quarter and Full Year 2024
Results and Recent Highlights More
- Ovid Therapeutics: Business Updates and Fourth
Quarter and Full Year 2024 Financial Results
More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- #AAD25: What You Need to Know From Amgen, Bristol
Myers, J&J and More More*
- More on BMS Data Supporting Potential for Sotyktu to
Impact Joint and Skin Symptoms More*
- Scientists in NYC Rally to Defend and Stand Up for
Science
More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:NYC Life Science Company Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- OPPORTUNITY: Head of CMC More
- OPPORTUNITY: Chief Product Officer
More
- OPPORTUNITY: Chief Medical Officer
More
- OPPORTUNITY: Department Chair of Vascular Surgery
More
- OPPORTUNITY: Vice President of Enterprise More
- OPPORTUNITY: Head of Operations More
- OPPORTUNITY: Vice President of Clinical Affairs More
- OPPORTUNITY: Laboratory Leader More
- OPPORTUNITY: Senior Manufacturing Engineer More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
